• Amgen announces global diagnostic collaborations worldpharmanews
    January 14, 2020
    Amgen announced strategic collaborations with leading diagnostic companies Guardant Health, Inc. and QIAGEN N.V. to develop blood- and tissue-based companion diagnostics (CDx), respectively, for investigational cancer treatment AMG 510.
PharmaSources Customer Service